COVID-19 (Coronavirus Disease) is caused by the novel coronavirus SARS-CoV-2, which is a RNA virus.

SEATTLE, WASHINGTON, UNITED STATES, February 3, 2022 /EINPresswire.com/ -- COVID-19 Nasal Swab Test Market Research focuses on the key trends prevailing in the Global COVID-19 Nasal Swab Test Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation for global market share, revenue and CAGR.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4629

Nasal swabs are used to collect secretions from the inner surface of nostril in order to diagnose various diseases including COVID-19. The global COVID-19 nasal swab test market is estimated to be valued at US$ 111.3 Mn in 2021, and is expected to exhibit a CAGR of 2.6% over the forecast period (2021-2028).

Market Drivers

Emergence of Covid-19 is expected to propel growth of the global COVID-19 nasal swab test market over the forecast period. For instance, globally, as of 5:35pm CET, 1 February 2022, there have been 376,478,335 confirmed cases of COVID-19, including 5,666,064 deaths, reported to WHO. As of 31 January 2022, a total of 9,901,135,980 vaccine doses have been administered.

Moreover, approval and launch of new products is also expected to propel growth of the global COVID-19 nasal swab test market over the forecast period. For example, Roche Diagnostics, in partnership with SD Biosensor Inc., a Korean technology solutions provider, launched a new rapid antigen COVID-19 nasal swab test that provides results within 15 minutes, in March 2021.

Market Opportunities

Funding for R&D in diagnostics solutions for COVID-19 is expected to offer lucrative growth opportunities for players in the global COVID-19 nasal swab test market. For example, in July 2020, National Institutes of Health announced plans to spend US$ 248.7 million for R&D in diagnostics solutions for COVID-19.

Moreover, R&D of advanced diagnostics solutions for COVID-19 is also expected to offer lucrative growth opportunities for players in the global COVID-19 nasal swab test market. For example, in July 2020, Helix OpCo, LLC announced development of standardized nasal swab kits in bulk for the collection of nasal secretion samples to detect SARS-CoV-2.

Market Trends

The global COVID-19 nasal swab test market is witnessing adoption of partnership activities. For example, Accumen Inc. partnered with EnvisionTec, a Germany-based technology company, to manufacture 3D printed nasal swabs for diagnosis of COVID-19.

The global COVID-19 nasal swab test market is also witnessing R&D of low cost products. For example, Innovation Lab, Aga Khan University, Pakistan, in May 2020, reported development of low-cost, 3-D printed prototype of nasal swab for the detection of SARS-CoV-2.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/4629

3D printing can be used to produce nasal swabs. For instance, in September 2020, 3D MEDiTech, a medical devices company, in collaboration with University of Melbourne, Australia, boosted the production of the first indigenous 3-D printed nasal swab for diagnosis of COVID-19. The new swabs, according to a study published in Medical Journal of Australia in May 2020, were as effective as commercially available nasal swabs.

Market Restraints

Product recall is expected to hinder growth of the COVID-19 nasal swab test market. For example, Health Canada in May 2020, recalled Spartan Bioscience, Inc.’s rapid COVID-19 diagnostic kits due to efficacy concerns of the product.

Key Players

Major players operating in the global COVID-19 nasal swab test market include, 3M Corporation, Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, Cepheid, GenMark Diagnostics, Inc., LumiraDx Ltd., Fluidigm Corporation, Lucira Health, Mesa Biotech, Inc., OraSure Technologies, Inc., PrivaPath Diagnostics Limited, QIAGEN N.V., Quidel Corporation, Roche Holding AG, Siemens Healthineers AG, and Sherlock Biosciences.

Segmentation

On the basis of product type, the global COVID-19 nasal swab test market is segmented into:

Foam Tipped Swabs

Non-Woven

Others

On the basis of diagnostics type, the global COVID-19 nasal swab test market is segmented into:

Molecular Diagnostics

CRISPR & Biosensors

Others

On the basis of mode, the global COVID-19 nasal swab test market is segmented into:

Point-of-Care

Non Point-of-Care

On the basis of end user, the global COVID-19 nasal swab test market is segmented into:

Hospital & Clinic

Laboratories & Diagnostics Centers

Others

On the basis of region, the global COVID-19 nasal swab test market is segmented into:

North America

U.S.

Canada

Latin America

Brazil

Argentina

Mexico

Rest of Latin America

Europe

Germany

U.K

Spain

France

Italy

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

GCC Countries

Israel

Rest of Middle East

Africa

South Africa

North Africa

Central Africa

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/insight/buy-now/4629

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.